Compounds > 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide
Page last updated: 2024-09-03

1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide and dinitrofluorobenzene

1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide has been researched along with dinitrofluorobenzene in 1 studies

Compound Research Comparison

Studies
(1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide)		Trials
(1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide)		Recent Studies (post-2010)
(1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide)		Studies
(dinitrofluorobenzene)		Trials
(dinitrofluorobenzene)		Recent Studies (post-2010) (dinitrofluorobenzene)
52021,5201313

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aubonney, N; Beavil, RL; Bonnefoy, JY; Gould, HJ; Graber, P1

Other Studies

1 other study(ies) available for 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide and dinitrofluorobenzene

ArticleYear
CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution.
    Immunology, 1995, Volume: 84, Issue:2

    Topics: B-Lymphocytes; Cell Line; Dinitrofluorobenzene; Ethyldimethylaminopropyl Carbodiimide; Humans; Immunoglobulin Fragments; Molecular Weight; Receptors, IgE

1995